
|Articles|May 17, 2019
When to consider corneal cross-linking treatment
Author(s)Julianne Mobilian
Audrey Talley Rostov, MD, discusses corneal cross-linking (CXL) complications, and when to consider CXL treatment
Advertisement
RELATED:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
NCX 470 gains positive regulatory feedback in China ahead of US NDA submission
2
DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes
3
FDA accepts Outlook Therapeutics' resubmitted BLA for ONS-5010 (LYTENAVA)
4
Tinlarebant NDA submission completed for Stargardt disease type 1, targeting first approved therapy
5





















